News

New weight-loss drug Wegovy is here, but is it a magical solution? Experts weigh in
Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...
Medical Dialogues6d
Weight loss drug: Novo Nordisk Wegovy now available in India
Mumbai: Novo Nordisk, a global healthcare company headquartered in Denmark, has announced the launch of Wegovy (injectable ...
New Atlas5d
Ozempic improves sugar control in certain type 1 diabetics, trial shows
A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use ...
Could Ozempic Treat Migraines, Too? Small Study Finds Early Promise for GLP-1s
People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, ...
Novo Nordisk’s Wegovy debuts in India: How it works, who it’s for, and how much it costs
Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...
pharmaphorum4d
The Ozempic dilemma: Balancing demand, supply, and patient safety in a viral GLP-1 world
The sudden and overwhelming demand for GLP-1 agonists, like Ozempic and Wegovy, has placed immense pressure on pharmaceutical supply chains. What started as a treatment for type 2 diabetes has ...